Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity

Aim: In renal cell carcinoma (RCC), tumor heterogeneity generated challenges to biomarker development and therapeutic management, often becoming responsible for primary and acquired drug resistance. This study aimed to assess the inter-tumoral, intra-tumoral, and intra-lesional heterogeneity of know...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Melissa Bersanelli, Letizia Gnetti, Francesco Paolo Pilato, Elena Varotti, Federico Quaini, Nicoletta Campanini, Elena Rapacchi, Roberta Camisa, Paolo Carbognani, Enrico Maria Silini, Michele Rusca, Francesco Leonardi, Umberto Maestroni, Mimma Rizzo, Matteo Brunelli, Sebastiano Buti, Luca Ampollini
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Open Exploration Publishing Inc. 2023-08-01
Saila:	Exploration of Targeted Anti-tumor Therapy
Gaiak:	renal carcinoma biomarkers heterogeneity immunohistochemistry
Sarrera elektronikoa:	https://www.explorationpub.com/Journals/etat/Article/1002165
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!